Back to search
Double blind controlled clinical trial of radiation plus razoxane (ICRF 159) versus radiation plus placebo in the treatment of head and neck cancer
Data up to Jan 2025
Published1978
Citations19
References7
Total Citations Per Year
Abstract
References (7)
Sequential Medical Plans
1952 • 209 citations
The role of chemotherapy in the management of cancer of the head and neck: A review
1975 • 108 citations
The integration of chemotherapy into a combined modality approach to cancer therapy
1975 • 103 citations
Combined therapy in advanced head and neck cancer: a randomized study.
1972 • 72 citations
ICRF 159, (±) 1,2-di(3,5-dioxopiperazin-1-yl)propane NSC-129,943; Razoxane
1976 • 56 citations
Synergism of ICRF 159 and radiotherapy in treatment of experimental tumors
1974 • 48 citations
Clinical use of radiation sensitizing agents
1974 • 23 citations
Cited By (0)
Loading...